These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 9545856

  • 21. [Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism].
    Chen XP, Wu ZD, Qiu FZ.
    Zhonghua Wai Ke Za Zhi; 2005 Apr 01; 43(7):442-6. PubMed ID: 15854370
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prognostic factors for hepatocellular carcinoma < or = 3 cm in diameter.
    Hu RH, Lee PH, Chang YC, Yu SC, Ho MC, Wu YM.
    Hepatogastroenterology; 2003 Apr 01; 50(54):2043-8. PubMed ID: 14696462
    [Abstract] [Full Text] [Related]

  • 27. [Fibrolamellar hepatocellular cancer].
    Ormann W.
    Leber Magen Darm; 1993 May 01; 23(3):128-31. PubMed ID: 8392127
    [Abstract] [Full Text] [Related]

  • 28. Comparison of liver resection for hepatocellular carcinoma in hepatitis B and hepatitis C-related cirrhotic patients.
    Wu CC, Tang JS, Lin MC, Yeh DC, Liu TJ, P'eng FK.
    Hepatogastroenterology; 1999 May 01; 46(26):651-5. PubMed ID: 10370591
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M, Vigano' L, Ferrero A, Pellerito R, Carbonatto P, Capussotti L.
    Eur J Surg Oncol; 2007 Feb 01; 33(1):61-6. PubMed ID: 17175128
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma.
    Choi GH, Kim DH, Kang CM, Kim KS, Choi JS, Lee WJ, Kim BR.
    Ann Surg Oncol; 2008 Feb 01; 15(2):618-29. PubMed ID: 18004628
    [Abstract] [Full Text] [Related]

  • 37. Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma.
    Paquet KJ, Gad HA, Lazar A, Koussouris P, Mercado MA, Heine WD, Jachman-Jahn V, Ruppert W.
    Eur J Surg; 1998 Jul 01; 164(7):513-9. PubMed ID: 9696973
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J, Wu Z, Tang Z.
    Zhonghua Wai Ke Za Zhi; 2001 Oct 01; 39(10):745-8. PubMed ID: 16201184
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.